Keeping up (just barely) with SARS
Reporting on the outbreak of severe acute respiratory syndrome (SARS) is shooting at a moving target; what follows can only be a snapshot of how things looked at the end of May, when this issue of Contemporary Pediatrics went to press.
Recent Videos
Related Content
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024Article
The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.
